Ascelia Pharma AB (publ) (STO:ACE)

Ascelia Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	38.05	49.86	75.26	21.86	149.56	261.6
Cash & Short-Term Investments	38.05	49.86	75.26	21.86	149.56	261.6
Cash Growth	-37.05%	-33.75%	244.34%	-85.39%	-42.83%	41.64%
Other Receivables	3.51	3.3	6.1	2.99	5.16	5.87
Receivables	3.51	3.3	6.1	2.99	5.16	5.87
Prepaid Expenses	0.97	0.63	0.61	0.66	0.79	0.96
Other Current Assets	0.14	0.15	1.75	3.43	5.36	6.18
Total Current Assets	42.67	53.94	83.72	28.94	160.87	274.61
Property, Plant & Equipment	0.49	0.94	0.12	1.06	0.63	1.82
Other Intangible Assets	57.07	57.07	57.08	57.07	57.07	57.06
Other Long-Term Assets	-	-0	-	-0	0	-
Total Assets	100.23	111.94	140.92	87.07	218.57	333.49

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.26	2.04	4.73	1.53	15.88	6.15
Accrued Expenses	6.85	8.48	12.73	8.52	19.66	16.34
Short-Term Debt	-	-	25.23	-	-	-
Current Portion of Leases	0.49	0.9	0.17	0.88	0.29	1.1
Current Income Taxes Payable	-	-	-	-	-	0.01
Other Current Liabilities	0.78	0.97	19.11	1.64	1.69	1.51
Total Current Liabilities	10.37	12.4	61.98	12.57	37.52	25.11
Long-Term Leases	-	0.07	-	0.18	0.19	0.55
Other Long-Term Liabilities	0.03	-	-	-	-0	-
Total Liabilities	10.4	12.47	61.98	12.74	37.71	25.66

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	134.57	127.9	97.19	34.87	34.87	34.58
Additional Paid-In Capital	784.7	771.37	721.75	678.75	678.75	678.83
Retained Earnings	-830.67	-800.9	-740.97	-639.96	-533.73	-405.83
Comprehensive Income & Other	1.23	1.11	0.97	0.67	0.97	0.25
Shareholders' Equity	89.83	99.47	78.94	74.33	180.86	307.83
Total Liabilities & Equity	100.23	111.94	140.92	87.07	218.57	333.49

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.49	0.97	25.4	1.06	0.48	1.66
Net Cash (Debt)	37.56	48.89	49.86	20.8	149.07	259.94
Net Cash Growth	-28.10%	-1.94%	139.76%	-86.05%	-42.65%	42.12%
Net Cash Per Share	0.30	0.43	0.92	0.62	4.28	7.89
Filing Date Shares Outstanding	131.92	126.87	96.11	33.76	33.67	33.67
Total Common Shares Outstanding	131.92	126.87	96.11	33.76	33.67	33.67
Working Capital	32.3	41.54	21.74	16.37	123.35	249.51
Book Value Per Share	0.68	0.78	0.82	2.20	5.37	9.14
Tangible Book Value	32.75	42.4	21.87	17.25	123.79	250.77
Tangible Book Value Per Share	0.25	0.33	0.23	0.51	3.68	7.45
Machinery	-	0.66	0.6	0.6	0.6	0.6

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error